Taking stock of the drug industry, from the lab to the medicine chest STAT+: Pfizer sues two former employees for stealing trade secrets and creating a rival for diabetes and obesity drugs By Ed Silverman Richard Drew/AP Pfizer alleges that two former employees stole trade secrets and used them to develop diabetes and obesity drugs. Read More STAT+: PhRMA takes aim at WHO and European Union over support of weakening patent protections By Ed Silverman Adobe PhRMA argues "the WHO and other agencies are seeking to undermine and even eliminate intellectual property protections" that drive innovation. Read More STAT+: Such a deal! Covid-19 therapies appear cost-effective … for now By Ed Silverman Merck "The drugs are fairly priced for the benefits that we can perceive," said Steve Pearson of the Institute for Clinical and Economic Review. Read More Sponsor content by STAT Events The Exhaustion Epidemic: Examining the Covid-19 Burnout Crisis in Health Care Join STAT on Feb. 7 to discuss the solutions needed to support and retain health care workers experiencing burnout at unprecedented levels. Register here. STAT+: With Alzheimer's drug sales weak, Biogen offers a disappointing financial outlook for 2022 By Adam Feuerstein and Damian Garde Ruby Wallau for STAT Sales of Aduhelm, Biogen’s treatment for Alzheimer’s disease, continued to underperform expectations in the fourth quarter. Read More Thursday, February 3, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments